PL353933A1 - Sposób wytwarzania opartych na polikationach biokoSposób wytwarzania opartych na polikationach biokoniugatów nadających się do transportowania różnegoniugatów nadających się do transportowania różnego rodzaju substancji czynnych w organizmie rodzaju substancji czynnych w organizmie - Google Patents

Sposób wytwarzania opartych na polikationach biokoSposób wytwarzania opartych na polikationach biokoniugatów nadających się do transportowania różnegoniugatów nadających się do transportowania różnego rodzaju substancji czynnych w organizmie rodzaju substancji czynnych w organizmie

Info

Publication number
PL353933A1
PL353933A1 PL00353933A PL35393300A PL353933A1 PL 353933 A1 PL353933 A1 PL 353933A1 PL 00353933 A PL00353933 A PL 00353933A PL 35393300 A PL35393300 A PL 35393300A PL 353933 A1 PL353933 A1 PL 353933A1
Authority
PL
Poland
Prior art keywords
polycation
molecules
polycations
bioconjugates
polycation bioconjugates
Prior art date
Application number
PL00353933A
Other languages
English (en)
Inventor
PeterSzego Peter Szego
Original Assignee
PeterSzego Peter Szego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PeterSzego Peter Szego filed Critical PeterSzego Peter Szego
Publication of PL353933A1 publication Critical patent/PL353933A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL00353933A 1999-06-29 2000-06-28 Sposób wytwarzania opartych na polikationach biokoSposób wytwarzania opartych na polikationach biokoniugatów nadających się do transportowania różnegoniugatów nadających się do transportowania różnego rodzaju substancji czynnych w organizmie rodzaju substancji czynnych w organizmie PL353933A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902217A HUP9902217A3 (en) 1999-06-29 1999-06-29 Polycation based bioconjugates and process for producing thereof
PCT/HU2000/000061 WO2001000242A2 (en) 1999-06-29 2000-06-28 Polycation-based bioconjugates

Publications (1)

Publication Number Publication Date
PL353933A1 true PL353933A1 (pl) 2003-12-15

Family

ID=89998595

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353933A PL353933A1 (pl) 1999-06-29 2000-06-28 Sposób wytwarzania opartych na polikationach biokoSposób wytwarzania opartych na polikationach biokoniugatów nadających się do transportowania różnegoniugatów nadających się do transportowania różnego rodzaju substancji czynnych w organizmie rodzaju substancji czynnych w organizmie

Country Status (23)

Country Link
US (2) US6727347B1 (pl)
EP (1) EP1202748B1 (pl)
JP (1) JP2003503363A (pl)
KR (1) KR100795093B1 (pl)
CN (1) CN1371288A (pl)
AT (1) ATE408420T1 (pl)
AU (1) AU784031B2 (pl)
BR (1) BR0012633A (pl)
CA (1) CA2377074A1 (pl)
CZ (1) CZ20014701A3 (pl)
DE (1) DE60040294D1 (pl)
EE (1) EE200100715A (pl)
HU (1) HUP9902217A3 (pl)
IL (2) IL147380A0 (pl)
MX (1) MXPA02000450A (pl)
NO (1) NO20016391L (pl)
NZ (1) NZ516666A (pl)
PL (1) PL353933A1 (pl)
RU (1) RU2250782C2 (pl)
SK (1) SK19222001A3 (pl)
UA (1) UA76940C2 (pl)
WO (1) WO2001000242A2 (pl)
ZA (1) ZA200200266B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9902217A3 (en) * 1999-06-29 2002-07-29 Szegoe Peter Polycation based bioconjugates and process for producing thereof
AU8149901A (en) * 2000-03-21 2001-10-03 Wisconsin Alummi Res Foundatio Methods and reagents for regulation of cellular responses in biological systems
EP1615665A4 (en) * 2003-04-10 2010-10-06 3M Innovative Properties Co DISTRIBUTION OF THE IMMUNE RESPONSE MODIFYING LINKS
RU2270690C1 (ru) * 2004-06-11 2006-02-27 Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") Комплексное анти-вич соединение
US8168922B2 (en) * 2004-10-18 2012-05-01 Lincoln Global, Inc. Self-shielded flux cored electrode
US7834065B2 (en) * 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
JP4989039B2 (ja) * 2005-04-27 2012-08-01 Ｊｎｃ株式会社 核酸複合体及びそれを用いる細胞内への核酸導入方法
TW200800235A (en) * 2005-10-18 2008-01-01 Otsuka Pharma Co Ltd Carrier composition for nucleic acid transport
CN102124098B (zh) 2008-06-27 2014-03-12 博傲沃德株式会社 细胞及组织的冷冻保存用组合物
CN101891889B (zh) * 2010-08-18 2012-05-23 中国科学院长春应用化学研究所 阳离子聚合物及其制备方法
US8541556B1 (en) 2012-03-02 2013-09-24 Empire Technology Development Llc Lignin derivatives and uses thereof
US9095142B2 (en) 2012-06-28 2015-08-04 Empire Technology Development Llc Lignin derivatives having polycations and uses thereof
EP2944195A1 (en) * 2014-05-15 2015-11-18 Monier Tadros Negatively charged matrix and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701521A (en) 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
US4847240A (en) 1978-01-16 1989-07-11 The Trustees Of Boston University Method of effecting cellular uptake of molecules
JPS6356501A (ja) * 1986-08-26 1988-03-11 Chisso Corp アフイニテイークロマトグラフイー用カラム充填剤及びその製造方法
HU202553B (en) 1987-10-21 1991-03-28 Mta Kutatas Es Szervezetelemzo Process for producing isopolypeptides composed of diamino monokarboxylic acids and pharmaceutical compositions comprising same, as well as plant protective comprising polyisolysine
JPH0413741A (ja) * 1990-05-02 1992-01-17 Chisso Corp ペクチン・ポリリシン高分子電解質複合体
JPH05246963A (ja) * 1992-03-02 1993-09-24 Kanegafuchi Chem Ind Co Ltd ε−ポリリジン誘導体
DE4331011A1 (de) * 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik
EP0915832B1 (en) * 1996-08-05 2002-10-02 Prolinx, Inc. Boronic compound complexing reagents and highly stable complexes
JP4606524B2 (ja) * 1997-11-19 2011-01-05 チッソ株式会社 ポリリジン、及びポリリジンの製造方法、及びポリリジン組成物、及びエンドトキシンを除去する医薬品の生産方法
HUP9902217A3 (en) * 1999-06-29 2002-07-29 Szegoe Peter Polycation based bioconjugates and process for producing thereof

Also Published As

Publication number Publication date
CZ20014701A3 (cs) 2002-06-12
EE200100715A (et) 2003-02-17
ATE408420T1 (de) 2008-10-15
US7090846B2 (en) 2006-08-15
RU2250782C2 (ru) 2005-04-27
IL147380A0 (en) 2002-08-14
UA76940C2 (en) 2006-10-16
HU9902217D0 (en) 1999-08-30
DE60040294D1 (de) 2008-10-30
US6727347B1 (en) 2004-04-27
NO20016391D0 (no) 2001-12-27
CN1371288A (zh) 2002-09-25
US20040220083A1 (en) 2004-11-04
AU5835100A (en) 2001-01-31
SK19222001A3 (sk) 2004-05-04
HUP9902217A3 (en) 2002-07-29
CA2377074A1 (en) 2001-01-04
MXPA02000450A (es) 2002-07-02
KR100795093B1 (ko) 2008-01-17
WO2001000242A2 (en) 2001-01-04
ZA200200266B (en) 2003-06-25
EP1202748A2 (en) 2002-05-08
JP2003503363A (ja) 2003-01-28
AU784031B2 (en) 2006-01-19
EP1202748B1 (en) 2008-09-17
WO2001000242A3 (en) 2001-11-22
NZ516666A (en) 2004-04-30
KR20020031352A (ko) 2002-05-01
NO20016391L (no) 2002-02-04
IL147380A (en) 2007-02-11
HUP9902217A2 (hu) 2001-04-28
BR0012633A (pt) 2002-04-02

Similar Documents

Publication Publication Date Title
PL353933A1 (pl) Sposób wytwarzania opartych na polikationach biokoSposób wytwarzania opartych na polikationach biokoniugatów nadających się do transportowania różnegoniugatów nadających się do transportowania różnego rodzaju substancji czynnych w organizmie rodzaju substancji czynnych w organizmie
DE69330715D1 (de) Antitumor quinazoline
ATE264685T1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
WO1999035170A8 (en) Compositions and methods for the treatment of tumor
WO2004080425A3 (en) Polypeptide compounds for inhibiting angiogenesis and tumor growth
EA200900049A1 (ru) Обработка изделий, в частности содержащих целлюлозу изделий и(или) помещений
GB9912476D0 (en) Organic compounds
WO1999014327A3 (en) Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
ATE242630T1 (de) Beladene bakterienghosts als träger- und targetingvehikel
AU2290000A (en) Phenanthridine-n-oxides with pde-iv inhibiting activity
SI1147088T1 (sl) 6-arilfenantridini s PDE-IV inhibirajoco aktivnostjo
WO2000032765A3 (en) Ribozyme therapy for the treatment and/or prevention of restenosis
MXPA02006167A (es) Promocion de la angiogenesis con survivina.
MXPA02005045A (es) Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer.
GB9916810D0 (en) Killing cells
PT1435991E (pt) Utilização de aplidina para o tratamento de cancro pancreático
WO2004014319A3 (en) Screening strategy for anticancer drugs
WO1999039009A8 (en) Processes for isolating, amplifying and characterizing dna
DE60011677D1 (en) Tryptase-inhibitoren
EP1462113A4 (en) CELL GROWTH INHIBITORS WITH ANTI-PEPT ANTIBODIES
YU102904A (en) A method and unit load for distributing articles
WO2003026696A1 (fr) Procede permettant de maitriser la proliferation de cellules cancereuses et la mort cellulaire
WO2000015175A3 (en) Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells
IL142088A0 (en) Methods and compositions for inhibiting neoplastic cell growth
WO2004091516A3 (en) Methods for controlling the proliferation of cells

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)